Literature DB >> 4672589

Etiology and therapy of thrombocytopenia associated with sarcoidosis.

J D Dickerman, P R Holbrook, W H Zinkham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4672589     DOI: 10.1016/s0022-3476(72)80098-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  9 in total

1.  Life threatening thrombocytopenia in sarcoidosis.

Authors:  A J Larner; C T Dollery; T M Cox; S R Bloom; J G Scadding; A J Rees
Journal:  BMJ       Date:  1990-02-03

2.  Thrombocytopenia, haemolytic anaemia, and sarcoidosis.

Authors:  P Semple
Journal:  Br Med J       Date:  1975-11-22

3.  Letter: Thrombocytopenia, haemolytic anaemia, and sarcoidosis.

Authors:  P J Holt; C A Wardrop; E Waddington
Journal:  Br Med J       Date:  1976-01-31

4.  Sarcoidosis presenting as chronic thrombocytopenia.

Authors:  S K Field; M C Poon
Journal:  West J Med       Date:  1987-04

5.  Cimetidine and thrombocytopenia.

Authors:  A J Isaacs
Journal:  Br Med J       Date:  1980-02-02

Review 6.  Pathogenesis of sarcoidosis.

Authors:  K Van Gundy; O P Sharma
Journal:  West J Med       Date:  1987-08

7.  Immune Thrombocytopenic Purpura Secondary to Sarcoidosis.

Authors:  Aisha Barlas; Lintu Ramachandran
Journal:  Maedica (Bucur)       Date:  2022-03

8.  Successful therapy of sarcoidosis-associated thrombocytopenia refractory to corticosteroids by a single course of human gammaglobulins.

Authors:  M Henke; H Engler; R Engelhardt; G W Löhr
Journal:  Klin Wochenschr       Date:  1986-11-17

9.  Sarcoidosis presenting with severe thrombocytopenia and arthritis.

Authors:  A J Swaak; W H Hissink-Muller; R M Van Soesbergen
Journal:  Clin Rheumatol       Date:  1982-09       Impact factor: 2.980

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.